Company intelligence / Profile preview

Robbins Emerging Opportunities

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Robbins Emerging Opportunities (REO) is a private investment firm that specializes in the life sciences and healthcare sectors. The firm focuses on identifying and investing in emerging growth companies that are developing innovative medical technologies, therapeutics, and healthcare services. REO often takes strategic positions in small-cap and micro-cap public companies, providing capital and advisory support to help management teams scale their operations. Their portfolio includes a diverse range of entities involved in biotechnology, medical devices, and digital health solutions.

Industry: Investors

Beyond the preview

Go deeper on Robbins Emerging Opportunities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Robbins Emerging Opportunities.

Explore the full profile